<SEC-DOCUMENT>0001104659-21-016888-index.html : 20210209
<SEC-HEADER>0001104659-21-016888.hdr.sgml : 20210209
<ACCEPTANCE-DATETIME>20210209211516
ACCESSION NUMBER:		0001104659-21-016888
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20210209
FILED AS OF DATE:		20210209
DATE AS OF CHANGE:		20210209

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			SALMON Pharma GmbH
		CENTRAL INDEX KEY:			0001843677
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40034
		FILM NUMBER:		21608855

	BUSINESS ADDRESS:	
		STREET 1:		SANKT-JACOBS-STRASSE 90
		STREET 2:		CH-9002
		CITY:			BASEL
		STATE:			V8
		ZIP:			4052
		BUSINESS PHONE:		61 3137965

	MAIL ADDRESS:	
		STREET 1:		SANKT-JACOBS-STRASSE 90
		STREET 2:		CH-9002
		CITY:			BASEL
		STATE:			V8
		ZIP:			4052

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vallon Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001824293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				824369909
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		TWO LOGAN SQUARE
		STREET 2:		100 N. 18TH STREET, SUITE 300
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
		BUSINESS PHONE:		(267) 207-3606

	MAIL ADDRESS:	
		STREET 1:		TWO LOGAN SQUARE
		STREET 2:		100 N. 18TH STREET, SUITE 300
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19103
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>tm214979-2_3seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm214979-2_3seq1.html

Document 1 - RAW XML: tm214979-2_3seq1.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>tm214979d2_ex24.htm
<DESCRIPTION>EXHIBIT 24
<TEXT>
Document 2 - file: tm214979d2_ex24.htm

</DOCUMENT>
</SEC-DOCUMENT>